Historique
Auteur A. CUNNINGHAM
Documents disponibles écrits par cet auteur (17)
Ajouter le résultat à votre sélection Affiner la recherche
This report examines the role of Europe in the production and trafficking of captagon tablets. It includes an historical background, current production and trafficking, seizures, the consumer market, production within the EU, forensic analysis a[...]
OEDT = EMCDDA ; L. LANIEL ; M. GANDILHON ; J. E. ADES ; A. CUNNINGHAM ; N. SINGLETON ; R. SEDEFOV ; P. GRIFFITHS | 2018
RapportCaptagon is reported to be a commonly used stimulant in the Middle East. In addition, some recent media reports have linked this drug to perpetrators of terrorist acts in Europe or terrorist groups based in areas of conflict in the Middle East. [...]
J. MOUNTENEY ; P. GRIFFITHS ; A. CUNNINGHAM ; M. EVANS-BROWN ; M. FERRI ; D. HEDRICH ; A. NOOR | 2016
Dans Drugs: Education, Prevention and Policy (Vol.23, n°6, December 2016) Article : PériodiqueMay 2016 saw the launch of the European Drug Report (EDR), the European Monitoring Centre for Drugs and Drug Addiction's (EMCDDA) annual review of the European drug situation, incorporating situational and trend analysis, statistical data and in[...]
OEDT = EMCDDA ; T. FREEMAN ; T. GROSHKOVA ; A. CUNNINGHAM ; P. GRIFFITHS ; D. POTTER ; S. CRAFT ; A. ENGLUND ; M. LYNSKEY ; R. SEDEFOV | 2019
RapportENGLISH: This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to in[...]Nouveauté
T. GROSHKOVA ; A. CUNNINGHAM ; L. ROYUELA ; N. SINGLETON ; T. SAGGERS ; R. SEDEFOV | 2018
Dans International Journal of Drug Policy (Vol.56, June 2018) Article : PériodiqueBackground: The importance of illicit drug price data and making appropriate adjustments for purity has been repeatedly highlighted for understanding illicit drug markets. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has [...]
This paper describes the significant developments that have occurred in the last 5 to 10 years in the field of drug precursors related to synthetic stimulant drugs produced in the EU. This includes describing the 'pre-precursor' phenomenon and r[...]Nouveauté
N. SINGLETON ; A. CUNNINGHAM ; T. GROSHKOVA ; L. ROYUELA ; R. SEDEFOV | 2018
Dans International Journal of Drug Policy (Vol.56, June 2018) Article : PériodiqueInterventions to tackle the supply of drugs are seen as standard components of illicit drug policies. Therefore drug market-related administrative data, such as seizures, price, purity and drug-related offending, are used in most countries for p[...]
This paper provides an analysis of the available data that suggest that a methamphetamine industry is rapidly being established in Afghanistan. The analysis provided is based on information from key informants, documentary sources and the analys[...]Nouveauté
M. QUIREYNS ; N. VAN WICHELEN ; T. BOOGAERTS ; T. SURMONT ; A. CUNNINGHAM ; J. MATIAS ; C. GYS ; A. COVACI ; A. L. N. VAN NUIJS | 2025
Dans International Journal of Drug Policy (Vol.139, May 2025) Article : PériodiqueBackground and aims: Estimating the retail drug market size is complex due to its clandestine nature, yet useful for intervention and policy planning. Wastewater-based epidemiology (WBE) offers an alternative strategy to estimate population-wide[...]
Concerns about the availability and use of methamphetamine in Europe have been growing for some time. Historically, the use of methamphetamine has been confined largely to the Czech Republic and Slovakia; however, recent signs of the spread of m[...]
T. P. FREEMAN ; T. GROSHKOVA ; A. CUNNINGHAM ; R. SEDEFOV ; P. GRIFFITHS ; M. T. LYNSKEY | 2019
Dans Addiction (Vol.114, n°6, June 2019) Article : PériodiqueENGLISH: AIMS: To quantify changes in (i) potency (concentration of Delta9-tetrahydrocannabinol; %THC), (ii) price (euros/g of cannabis) and (iii) value (mg THC/euro) of cannabis resin and herbal cannabis in Europe. DESIGN: Repeated cross-sect[...]
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; W. FRANCIS ; R. CHRISTIE ; A. CUNNINGHAM ; J. SEKULA ; A. ALMEIDA ; R. SEDEFOV | 2015
RapportFRANÇAIS : De nouvelles substances psychoactives (NSP ou «nouvelles drogues») ont été détectées dans l'Union européenne l'année dernière au rythme de deux par semaine environ. Au total, 101 nouvelles substances ont été signalées au système d'al[...]Nouveauté
J. MOUNTENEY ; P. GRIFFITHS ; A. BO ; A. CUNNINGHAM ; J. MATIAS ; A. PIRONA | 2018
Dans International Journal of Drug Policy (Vol.51, January 2018) Article : PériodiqueThis paper explores the recent resurgence in use of ecstasy/MDMA in Europe and highlights keys areas of continuity and divergence between the ecstasy market of the 1990s and the current MDMA market. Based on a scoping study involving a targeted [...]
OEDT = EMCDDA ; J. MOUNTENEY ; A. BO ; A. CUNNINGHAM ; I. GIRAUDON ; J. MATIAS ; A. PIRONA ; N. VAN GELDER ; A. RYBARSKA ; L. VANDAM ; P. GRIFFITHS | 2016
RapportThis report explores the recent resurgence in use of MDMA in Europe and increased availability of high-strength MDMA tablets, crystals and powders. It notes that the picture is not uniform across European countries, and while overall the region’[...]
This paper describes open-source information monitoring and how we use it at the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in the area of drug markets - what it is and, importantly, what it is not; the methodology for its [...]
